In the European pharmaceutical industry, strategic partnerships are more critical than ever due to evolving regulations, market consolidation, and supply chain complexities. Collaborations with local firms, research institutions, and distributors help navigate stringent EU regulations, expand market reach, and accelerate drug development. These alliances enhance credibility, streamline market entry, and ensure compliance in a highly competitive and rapidly changing landscape. As digital health, biotech innovation, and regulatory shifts reshape the sector, partnerships are key to staying agile and seizing new opportunities. In this presentation you will learn:

• What is key to building successful partnerships?
• How to navigate the radically changing political landscape?
• How can partnerships better support to navigate the complex regulatory landscapes?